Finally, we focused on the immune cell targets of IL-33, i.e. ST2-expressing cells; particularly Treg ST2+ cells, which display the highest expression of the IL-33 receptor in experimental acute hepatitis [21], and ILC2, which are essential downstream effectors in IL-33-mediated liver fibrosis [7]. The gene discussed is IL33; the disease is Acute hepatitis.